These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 11500957)
1. ERK 1,2 and p38 pathways are involved in the proliferative stimuli mediated by urokinase in osteoblastic SaOS-2 cell line. Juretic N; Santibáñez JF; Hurtado C; Martínez J J Cell Biochem; 2001 Jun 26-Jul 25; 83(1):92-8. PubMed ID: 11500957 [TBL] [Abstract][Full Text] [Related]
2. Growth factor-dependent activation of the MAPK pathway in human pancreatic cancer: MEK/ERK and p38 MAP kinase interaction in uPA synthesis. Lee KH; Hyun MS; Kim JR Clin Exp Metastasis; 2003; 20(6):499-505. PubMed ID: 14598883 [TBL] [Abstract][Full Text] [Related]
3. Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade. Lengyel E; Wang H; Gum R; Simon C; Wang Y; Boyd D Oncogene; 1997 May; 14(21):2563-73. PubMed ID: 9191056 [TBL] [Abstract][Full Text] [Related]
4. Activation of p42/44 and p38 mitogen-activated protein kinases by extracellular calcium-sensing receptor agonists induces mitogenic responses in the mouse osteoblastic MC3T3-E1 cell line. Yamaguchi T; Chattopadhyay N; Kifor O; Sanders JL; Brown EM Biochem Biophys Res Commun; 2000 Dec; 279(2):363-8. PubMed ID: 11118293 [TBL] [Abstract][Full Text] [Related]
5. Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation. Guicheux J; Lemonnier J; Ghayor C; Suzuki A; Palmer G; Caverzasio J J Bone Miner Res; 2003 Nov; 18(11):2060-8. PubMed ID: 14606520 [TBL] [Abstract][Full Text] [Related]
6. Divergent regulation by p44/p42 MAP kinase and p38 MAP kinase of bone morphogenetic protein-4-stimulated osteocalcin synthesis in osteoblasts. Kozawa O; Hatakeyama D; Uematsu T J Cell Biochem; 2002; 84(3):583-9. PubMed ID: 11813263 [TBL] [Abstract][Full Text] [Related]
7. Insulin activates p38 mitogen-activated protein (MAP) kinase via a MAP kinase kinase (MKK) 3/MKK 6 pathway in vascular smooth muscle cells. Igarashi M; Yamaguchi H; Hirata A; Daimon M; Tominaga M; Kato T Eur J Clin Invest; 2000 Aug; 30(8):668-77. PubMed ID: 10964158 [TBL] [Abstract][Full Text] [Related]
8. Basic fibroblast growth factor stimulates vascular endothelial growth factor release in osteoblasts: divergent regulation by p42/p44 mitogen-activated protein kinase and p38 mitogen-activated protein kinase. Tokuda H; Kozawa O; Uematsu T J Bone Miner Res; 2000 Dec; 15(12):2371-9. PubMed ID: 11127202 [TBL] [Abstract][Full Text] [Related]
9. T cells regulate the expression of matrix metalloproteinase in human osteoblasts via a dual mitogen-activated protein kinase mechanism. Rifas L; Arackal S Arthritis Rheum; 2003 Apr; 48(4):993-1001. PubMed ID: 12687541 [TBL] [Abstract][Full Text] [Related]
10. Regulation of hepatocyte growth factor-mediated urokinase plasminogen activator secretion by MEK/ERK activation in human stomach cancer cell lines. Lee KH; Choi EY; Kim MK; Hyun MS; Jang BI; Kim TN; Kim SW; Song SK; Kim JH; Kim JR Exp Mol Med; 2006 Feb; 38(1):27-35. PubMed ID: 16520550 [TBL] [Abstract][Full Text] [Related]
11. ERK signalling in metastatic human MDA-MB-231 breast carcinoma cells is adapted to obtain high urokinase expression and rapid cell proliferation. Seddighzadeh M; Zhou JN; Kronenwett U; Shoshan MC; Auer G; Sten-Linder M; Wiman B; Linder S Clin Exp Metastasis; 1999; 17(8):649-54. PubMed ID: 10919709 [TBL] [Abstract][Full Text] [Related]
12. Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells. Gallea S; Lallemand F; Atfi A; Rawadi G; Ramez V; Spinella-Jaegle S; Kawai S; Faucheu C; Huet L; Baron R; Roman-Roman S Bone; 2001 May; 28(5):491-8. PubMed ID: 11344048 [TBL] [Abstract][Full Text] [Related]
13. Cellular mechanisms of hepatocyte growth factor-mediated urokinase plasminogen activator secretion by MAPK signaling in hepatocellular carcinoma. Lee KH; Choi EY; Hyun MS; Eun JR; Jang BI; Kim TN; Lee HJ; Lee DS; Yun SS; Kim HJ; Kim JH; Kim JR Tumori; 2008; 94(4):523-30. PubMed ID: 18822689 [TBL] [Abstract][Full Text] [Related]
14. Growth inhibition of vascular smooth muscle cells derived from urokinase receptor (u-PAR)-deficient mice in the presence of carcinoma cells. Ueshima S; Fukao H; Okada K; Matsuo O Thromb Res; 2004; 113(1):41-9. PubMed ID: 15081564 [TBL] [Abstract][Full Text] [Related]
15. Diosmetin induces human osteoblastic differentiation through the protein kinase C/p38 and extracellular signal-regulated kinase 1/2 pathway. Hsu YL; Kuo PL J Bone Miner Res; 2008 Jun; 23(6):949-60. PubMed ID: 18269307 [TBL] [Abstract][Full Text] [Related]
16. Evidence for a role of p38 MAP kinase in expression of alkaline phosphatase during osteoblastic cell differentiation. Suzuki A; Guicheux J; Palmer G; Miura Y; Oiso Y; Bonjour JP; Caverzasio J Bone; 2002 Jan; 30(1):91-8. PubMed ID: 11792570 [TBL] [Abstract][Full Text] [Related]
17. Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor. Fibbi G; Caldini R; Chevanne M; Pucci M; Schiavone N; Morbidelli L; Parenti A; Granger HJ; Del Rosso M; Ziche M Lab Invest; 1998 Sep; 78(9):1109-19. PubMed ID: 9759655 [TBL] [Abstract][Full Text] [Related]
18. Lysophosphatidic acid is an osteoblast mitogen whose proliferative actions involve G(i) proteins and protein kinase C, but not P42/44 mitogen-activated protein kinases. Grey A; Banovic T; Naot D; Hill B; Callon K; Reid I; Cornish J Endocrinology; 2001 Mar; 142(3):1098-106. PubMed ID: 11181524 [TBL] [Abstract][Full Text] [Related]
19. Nicotine stimulates urokinase-type plasminogen activator receptor expression and cell invasiveness through mitogen-activated protein kinase and reactive oxygen species signaling in ECV304 endothelial cells. Khoi PN; Park JS; Kim NH; Jung YD Toxicol Appl Pharmacol; 2012 Mar; 259(2):248-56. PubMed ID: 22261521 [TBL] [Abstract][Full Text] [Related]
20. CTGF/Hcs24 induces chondrocyte differentiation through a p38 mitogen-activated protein kinase (p38MAPK), and proliferation through a p44/42 MAPK/extracellular-signal regulated kinase (ERK). Yosimichi G; Nakanishi T; Nishida T; Hattori T; Takano-Yamamoto T; Takigawa M Eur J Biochem; 2001 Dec; 268(23):6058-65. PubMed ID: 11732999 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]